News
-
Melbourne Dental School Head of School Mike Morgan, CSL Senior Vice President of Research Andrew Nash, University of Melbourne Vice-President (Enterprise) Doron Ben-Meir, COHR CEO & Director of Research Eric Reynolds, Member for Higgins Katie Allen and Brandon Capital Investment Manager Ingmar Wahlqvist at the launch of Denteric.
-
New research was published today [Cell Host and Microbe, 11 September] that shows how an important group of human pathogens cause disease, opening up fresh avenues for much needed therapies.
-
Congratulations to Bio21's Leann Tilley and David Ascher, who have received NHMRC Development and Investigator grants respectively.
-
An exciting new microscope has been installed in the Biochemistry and Molecular Biology Node of the Biological Optical Microscopy Platform at the Bio21 Institute, 28 August 2019.
-
Read about Justine Mintern, Biochemistry and Molecular Biology, Head of Vaccine Biology Lab
-
Major landmark development will significantly increase CSL’s presence in the Parkville biomedical precinct and cement Melbourne’s place as a world-class research destination
-
Capitalising on the revolution brought about by structural cryo-electron microscopy (cryo-EM), a Bio21 team led by Dr Mike Griffin and Prof Leann Tilley has generated molecular movies of a sophisticated nano-machine, called the proteasome.
-
Professor Karen Day has secured almost US$3 million funding from the NIH to further her world-leading malaria research at the Bio21 Institute.
-
Read Bio21's Ary Hoffmann's piece published in Pursuit about how the Wolbachia bateria may hold the key to controlling the spread of dengue fever, the Zika virus and other mosquito-borne diseases.
-
Art meets Science in this new exhibition at Quantum Victoria by artists Damon Kowarsky and Hyunju Kim's displaying artworks with a unique interpretation of the periodic table of chemical elements. Read this piece by Professor Frances Separovic published in The Conversation.